Vanquish Oncology's Series A - II Round

Vanquish Oncology raised a round of funding on April 10, 2014.

Vanquish Oncology is a drug development company focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet or underserved cancer markets. Th…

Articles about Vanquish Oncology's Series A - II Round: